LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 79

Search options

  1. Article ; Online: Causes and implications of increasing costs of prescription medications for allergists.

    Sun, Di / Codispoti, Christopher D

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2023  Volume 131, Issue 3, Page(s) 290–291

    MeSH term(s) Humans ; Allergists ; Causality ; Prescriptions
    Language English
    Publishing date 2023-03-21
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2023.05.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Health care access in allergy and immunology: Problems and potential solutions.

    Pappalardo, Andrea A / Codispoti, Christopher D / Mahdavinia, Mahboobeh

    The Journal of allergy and clinical immunology

    2023  Volume 153, Issue 2, Page(s) 401–403

    MeSH term(s) Humans ; Hypersensitivity/therapy ; Health Services Accessibility ; Allergy and Immunology
    Language English
    Publishing date 2023-11-04
    Publishing country United States
    Document type Editorial
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2023.10.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply to "Does asthma affect outcomes of patients with COVID-19 infections?"

    Mahdavinia, Mahboobeh / Codispoti, Christopher D

    The journal of allergy and clinical immunology. In practice

    2020  Volume 9, Issue 1, Page(s) 594–595

    MeSH term(s) Asthma/epidemiology ; COVID-19 ; Humans ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-09-28
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2020.09.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review.

    Codispoti, Christopher D / Greenhawt, Matthew / Oppenheimer, John

    The journal of allergy and clinical immunology. In practice

    2022  Volume 10, Issue 8, Page(s) 2109–2116

    Abstract: Background: Inconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely ... ...

    Abstract Background: Inconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely affect asthma.
    Objective: The purpose of this review is to identify health disparities associated with access to care for asthma, and cost-effectiveness of therapies and interventions addressing this health disparity.
    Methods: A narrative systematic review was undertaken using MeSH searches of English language articles published in CINAHL, Scopus, or PubMed.
    Results: A total of 725 articles were identified. Barriers recognized from the literature included access to diagnostic spirometry, access to specialists, medication formulary restrictions, and issues leading to medical nonadherence. Telemedicine, school-based health care interventions, digital applications, and non-office-based digital spirometry could be used to address these gaps in access to asthma care while potentially being cost-effective.
    Conclusion: With the widespread adoption of telemedicine because of the pandemic, and adoption of other mobile services, we now have potential tools that can increase access to asthma care, which can help address this health care inequity. Evidence is limited, but favorable, that some of these tools may be cost-effective.
    MeSH term(s) Asthma/epidemiology ; Asthma/therapy ; COVID-19/epidemiology ; Cost-Benefit Analysis ; Humans ; Pandemics ; Telemedicine
    Language English
    Publishing date 2022-05-05
    Publishing country United States
    Document type Journal Article ; Systematic Review
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2022.04.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Patient-Centered Practice Guidelines: GRADEing Evidence to Incorporate Certainty, Balance Between Benefits and Harms, Equity, Feasibility, and Cost-Effectiveness.

    Stephen, Ellen / Conway, Alexandra E / Codispoti, Christopher D / Abrams, Elissa / Lieberman, Jay A / Ledford, Dennis / Pongdee, Thanai / Shaker, Marcus

    The journal of allergy and clinical immunology. In practice

    2024  

    Abstract: The practice of medicine in recent years has emphasized the use of evidence-based clinical guidelines to help inform treatment decisions. Since its development in 2004, the GRADE (Grading of Recommendations Assessment, Development and Evaluation) ... ...

    Abstract The practice of medicine in recent years has emphasized the use of evidence-based clinical guidelines to help inform treatment decisions. Since its development in 2004, the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach has offered a systematic process for reviewing and summarizing the certainty of evidence found in the medical literature regarding various treatment options. To develop truly patient-centered care guidelines, this appraisal of the certainty of evidence must be combined with an understanding of the balance between benefits and harms, patient preferences, equity, feasibility, cost-effectiveness, and policy implications. This review examines each of these domains in detail, exploring the process and benefits of developing relevant, patient-focused guidelines directly applicable to the practice of modern medicine.
    Language English
    Publishing date 2024-03-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2024.03.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Practical Guide to Understanding Cost-Effectiveness Analyses.

    Greenhawt, Matthew / Oppenheimer, John / Codispoti, Christopher D

    The journal of allergy and clinical immunology. In practice

    2021  Volume 9, Issue 12, Page(s) 4200–4207

    Abstract: Cost-effectiveness analysis is a way to understand the value of a health care intervention in terms of assessing the money spent to produce beneficial outcomes. Cost-effectiveness analyses are used by various stakeholders for such purposes because health ...

    Abstract Cost-effectiveness analysis is a way to understand the value of a health care intervention in terms of assessing the money spent to produce beneficial outcomes. Cost-effectiveness analyses are used by various stakeholders for such purposes because health care resources and financing may be scarce, depending on the economy, and certain interventions may be costly to produce such outcomes compared with other options. These analyses are built on well-researched and robust inputs for costs and outcomes and may be modeled using a technique called Markov chain models, which allow transitions among various health states (eg, alive, dead, outgrow allergy, allergy relapses) relative to the condition of interest to reflect a base-case scenario. Then, the margins of the inputs are explored for a sensitivity analysis of potential findings. These analyses should be investigated from multiple perspectives (eg, society, health care payer). Limitations of the analysis should be clearly stated. Although such models are an informative way to explore a situation and can be performed without additional direct patient intervention, a weakness of the approach is that this may overlook individual patient nuances. Cost-effectiveness analyses are important policy tools to show, on average, an optimal way to improve value in population health.
    MeSH term(s) Cost-Benefit Analysis ; Humans ; Quality-Adjusted Life Years
    Language English
    Publishing date 2021-10-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2021.10.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.

    Codispoti, Christopher D / Mahdavinia, Mahboobeh

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2019  Volume 123, Issue 3, Page(s) 232–239

    Abstract: Objective: To identify the need for cost-effectiveness analysis of biologic therapies in the treatment of chronic rhinosinusitis (CRS).: Data sources: Clinical trials of monoclonal antibodies (omalizumab, benralizumab, mepolizumab and dupilumab) for ... ...

    Abstract Objective: To identify the need for cost-effectiveness analysis of biologic therapies in the treatment of chronic rhinosinusitis (CRS).
    Data sources: Clinical trials of monoclonal antibodies (omalizumab, benralizumab, mepolizumab and dupilumab) for nasal polyposis or chronic rhinosinusitis published on PubMed.
    Study selections: Clinical trials of biologic therapies in CRS and nasal polyposis.
    Results: No cost-effectiveness analyses of biologic therapies in CRS have been performed.
    Conclusion: As more clinical trials of biologic therapies for CRS are conducted, there is a need for cost-effectiveness analysis. Future analyses should consider these therapies as part of medical therapeutic options compared with surgery. To increase generalizability, analyses should include samples from allergy and primary care clinics rather than only otolaryngology clinics.
    MeSH term(s) Biological Therapy/economics ; Chronic Disease ; Cost-Benefit Analysis ; Health Services Accessibility ; Humans ; Nasal Polyps/economics ; Nasal Polyps/therapy ; Rhinitis/economics ; Rhinitis/therapy ; Sinusitis/economics ; Sinusitis/therapy ; United States ; United States Food and Drug Administration
    Language English
    Publishing date 2019-07-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2019.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Food sensitization and cardiovascular mortality: An intriguing association in need of further study.

    Shaker, Marcus / Abrams, Elissa M / Oppenheimer, John / Anagnostou, Aikaterini / Codispoti, Christopher D / Golden, David B K / Greenhawt, Matthew / Stukus, David / Moore-Clingenpeel, Melissa / Hughes, Sarah W / Mack, Douglas P / Mustafa, S Shahzad / Lang, David M

    The Journal of allergy and clinical immunology

    2024  Volume 153, Issue 4, Page(s) 1163–1165

    MeSH term(s) Humans ; Food/adverse effects ; Allergens ; Lung ; Cardiovascular Diseases ; Food Hypersensitivity
    Chemical Substances Allergens
    Language English
    Publishing date 2024-01-22
    Publishing country United States
    Document type Letter
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2023.12.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”

    Mahdavinia, Mahboobeh / Codispoti, Christopher D.

    The Journal of Allergy and Clinical Immunology: In Practice ; ISSN 2213-2198

    2020  

    Keywords Immunology and Allergy ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.jaip.2020.09.020
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top